Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | APEX1 | P27695 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.31 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20000082 | 0.79 | KDM4E (0.46) | KDM4EALDH1A1APEX1CYP2C19CA12 | |
| SCHEMBL24812540 | 0.74 | KDM4E (0.41) | KDM4EALDH1A1APEX1CYP2C19CA12 | |
| SCHEMBL21135674 | 0.71 | KDM4E (0.40) | KDM4EALDH1A1APEX1CYP2C19CA12 | |
| SCHEMBL1694754 | 0.70 | CA1 (0.43) | KDM4EALDH1A1CA12CA1CA2 | |
| SCHEMBL27019944 | 0.69 | CA1 (0.46) | CA12CA1CA2CA7CA13 | |
| SCHEMBL21135679 | 0.68 | KDM4E (0.38) | KDM4EALDH1A1APEX1CYP2C19CA12 | |
| SCHEMBL25162200 | 0.68 | — | — | |
| SCHEMBL14041257 | 0.67 | FABP3 (0.41) | — | |
| SCHEMBL6586893 | 0.65 | ALDH1A1 (0.48) | KDM4EALDH1A1APEX1CYP2C19CA12 | |
| SCHEMBL6363924 | 0.64 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10717706-B2 | M-phenylenediamine compound and method for producing polymer compound using same | FUJIFILM CORPORATION (JP) | 2020-07-21 | — | — | US | disclosed |
| US-20190177270-A1 | NOVEL M-PHENYLENEDIAMINE COMPOUND AND METHOD FOR PRODUCING POLYMER COMPOUND USING SAME | FUJIFILM CORPORATION (JP) | 2019-06-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190177270-A1 | NOVEL M-PHENYLENEDIAMINE COMPOUND AND METHOD FOR PRODUCING POLYMER COMPOUND USING SAME | PNMT, PRMT9, HRH3 | KDM4E 2711/4885ALDH1A1 3083/4885APEX1 2718/4885 |
| US-10717706-B2 | M-phenylenediamine compound and method for producing polymer compound using same | PNMT, HRH3, PRMT9 | KDM4E 2487/4885ALDH1A1 3143/4885APEX1 2616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.